ESPR - Esperion Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts12121312
Avg. Estimate0.97-1.56-4.02-2.4
Low Estimate-2.11-2.04-7.86-7.61
High Estimate3.89-0.28-1.111
Year Ago EPS-1.73-1.71-7.54-4.02
Revenue EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts11101211
Avg. Estimate79.03M6.37M100.8M183.48M
Low EstimateN/AN/AN/A128.13M
High Estimate150M37.5M150M242.5M
Year Ago SalesN/AN/AN/A100.8M
Sales Growth (year/est)N/AN/AN/A82.00%
Earnings History3/30/20186/29/20189/29/201812/30/2018
EPS Est.-1.56-1.72-1.63-1.42
EPS Actual-1.73-1.71-1.86-2.24
Difference-0.170.01-0.23-0.82
Surprise %-10.90%0.60%-14.10%-57.70%
EPS TrendCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Current Estimate0.97-1.56-4.02-2.4
7 Days Ago0.8-1.53-3.75-2.19
30 Days Ago0.95-1.67-3.85-1.97
60 Days Ago-0.84-1.39-4.79-3.79
90 Days Ago-0.84-1.39-4.82-3.94
EPS RevisionsCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days1N/AN/AN/A
Up Last 30 Days2121
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/A111
Growth EstimatesESPRIndustrySectorS&P 500
Current Qtr.156.10%N/AN/A-0.02
Next Qtr.8.80%N/AN/A0.04
Current Year46.70%N/AN/A0.05
Next Year40.30%N/AN/A0.11
Next 5 Years (per annum)26.20%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A